Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (1)
  • Antibiotic
    (1)
TargetMol | Tags By ResearchField
  • Immune System
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

oritavancin diphosphate

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    1
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
Other Forms of Products
  • Oritavancin(LY-333328)
    T37881171099-57-3
    Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci.
    • $85
    Inquiry
    Size
    QTY